Historical AI Consensus
This page preserves the research and market snapshot packaged for this batch. It is not updated with later prices or revised advisor outputs.
- Symbol
- 051910.KRX
- Batch
- 7
- Published
- September 20, 2026
- AI Advisors
- 14
Historical AI Consensus Investment Thesis
LG Chemicals (051910) Stock Forecast and AI Rating
Forecast targets and rating
Published batch rating
BUY
Calculated from the frozen synthesized path using the same return, horizon, volatility and dividend rules as individual opinions.
1-Year
NEUTRAL₩289,857
+8.6%+8.9% incl. dividends5-Year
BUY₩444,167
+66.4%+68.9% incl. dividendsPublished batch insight
Deep Asset Discount Unlocks High Conviction Specialty Materials Transformation
There is high consensus that peaking capital expenditure, domestic cracker rationalization, and external cathode contracts drive a structural turnaround. However, sharp divergence persists regarding holding company discount compression and debt burdens, positioning the enterprise for disciplined cash recovery while structural commodity overcapacity caps speculative upside.
This analysis preserves the original published batch. Audit published forecasts in full transparency
Universal Investor (Polymath), Ray Dalio (Strategist), Superintelligence (Anthropologist), Elon Musk (Visionary), Sherlock Holmes (Whistleblower), Warren Buffett (Value Purist), J.P. Morgan (Titan), Michael Burry (Vulture), Machiavelli (Insider). Some archetypes run in multiple modes, resulting in 14 advisors total.
Full published thesis
Executive Summary
If you invested $10,000 in LG Chemicals at the forecast anchor (2026-09-18): $16,696 in five years versus $13,892 for S&P 500 benchmark.
* Return is calculated incl. 0.3% net dividend yield for LG Chemicals.
20-quarter synthesized forecastPrice targets, quarterly returns and the reasoning behind each stepView tableClose table
Frozen forecast from 18 Sept 2026. Prices in KRW; returns exclude dividends. Each quarter is compounded from the previous quarter.
Swipe the table horizontally to read every column.
| Quarter | Target (KRW) | Quarter return | Total return | Forecast rationale |
|---|---|---|---|---|
| Q4 2026 | 266,672.55 | -0.12% | -0.12% | Elevated crude feedstocks and reverse inventory lagging compress basic chemical spreads, tempering sentiment. However, progress on the Yeosu restructuring framework and stable advanced materials shipments maintain a solid valuation floor. |
| Q1 2027 | 271,326.74 | +1.75% | +1.62% | Year-end disclosures confirm capital expenditure discipline alongside formal state support for domestic cracker consolidation. Lower capital outlays and activist engagement mitigate persistent seasonal petrochemical weakness, supporting modest price stabilization. |
| Q2 2027 | 280,055.27 | +3.22% | +4.89% | Commercial trial shipments from the Clarksville cathode facility commence, capturing North American sourcing premiums. Free cash flow burn narrows noticeably, triggering an initial relief rally across deeply discounted cyclical shares. |
| Q3 2027 | 289,857.20 | +3.50% | +8.56% | Initial block monetization of subsidiary shares injects non-dilutive liquidity to retire high-coupon parent borrowings. Deleveraging eases interest coverage pressure, initiating gradual compression in the persistent conglomerate holding discount. |
| Q4 2027 | 301,150.70 | +3.90% | +12.79% | Execution of promised shareholder returns from asset sales validates management discipline. Stable lithium pass-through contracts and growing grid-scale energy storage material demand offset routine year-end automotive manufacturing lulls. |
| Q1 2028 | 311,435.28 | +3.42% | +16.64% | Restructuring of uncompetitive domestic ethylene lines eliminates persistent operating cash drain. Advanced Materials operating profitability expands as external deliveries to tier-one automakers scale, driving consensus earnings revisions higher. |
| Q2 2028 | 322,923.12 | +3.69% | +20.94% | Consolidated free cash flow approaches sustainable breakeven as historical greenfield capital commitments roll off. Lower financing charges and recovering specialty engineering plastic volumes bolster investor confidence across institutional accounts. |
| Q3 2028 | 334,286.36 | +3.52% | +25.20% | Global monetary easing stabilizes export trade financing while grid storage demand accelerates cathode utilization. Modest equity gains reflect steady operational progress, constrained only by persistent regional basic chemical capacity. |
| Q4 2028 | 346,112.53 | +3.54% | +29.63% | Management activates enhanced capital return milestones, including targeted share retirements funded by asset sales. The parent holding discount narrows further as recurring cash flows support normalized dividend yields. |
| Q1 2029 | 350,912.39 | +1.39% | +31.43% | Periodic inventory rebalancing across Western automotive supply chains induces temporary revenue deceleration. Specialty electronic and semiconductor materials cushion segment gross margins, preventing significant retracement from cyclical recovery levels. |
| Q2 2029 | 363,591.59 | +3.61% | +36.18% | Tennessee manufacturing operations scale toward full commercial capacity, capturing localized production incentives. Operating leverage in battery materials lifts segment profitability, establishing Advanced Materials as the primary corporate earnings contributor. |
| Q3 2029 | 370,486.11 | +1.90% | +38.76% | A secondary tranche of subsidiary share monetization reduces consolidated debt-to-equity below conservative targets. Lower interest burdens improve per-share net income, reinforcing fundamental valuation support despite mature chemical market growth. |
| Q4 2029 | 382,579.33 | +3.26% | +43.29% | Annual free cash flow records a decisive positive surplus following consecutive years of capital rationing. Disciplined reinvestment and expanding bio-circular polymer contracts prompt sell-side desks to raise through-cycle valuation multiples. |
| Q1 2030 | 391,566.34 | +2.35% | +46.65% | Commercial qualification of next-generation solid-state battery electrolytes and high-voltage cathode formulations secures strategic development partnerships. Emerging technology leadership provides multiple support against commoditized Asian manufacturing peers. |
| Q2 2030 | 403,165.57 | +2.96% | +51.00% | Utility-scale energy storage deployments achieve record throughput, driving elevated utilization across consolidated battery material assets. Robust operating cash flows support balance sheet strength, enabling selective investments in high-barrier electronic materials. |
| Q3 2030 | 408,756.64 | +1.39% | +53.09% | Global industrial manufacturing growth stabilizes, providing predictable baseline demand for engineering plastics. Net debt amortization continues systematically, shielding consolidated earnings from persistent global interest rate fluctuations. |
| Q4 2030 | 418,821.30 | +2.46% | +56.86% | Finalization of the planned subsidiary divestment program toward target ownership thresholds cements a transparent capital structure. Cash proceeds deployed into debt retirement and dividends solidify investor confidence in corporate governance. |
| Q1 2031 | 426,209.94 | +1.76% | +59.63% | Operating execution stabilizes into a mature specialty materials profile, with diversified product lines dampening hydrocarbon cyclicality. Equity valuation grinds upward as return on equity converges toward normalized cost-of-capital benchmarks. |
| Q2 2031 | 435,658.94 | +2.22% | +63.17% | Long-term cathode supply agreement renewals with North American automotive consortiums lock in multi-year revenue visibility. High capacity utilization protects unit conversion margins, sustaining steady upward momentum into the summer quarter. |
| Q3 2031 | 444,166.62 | +1.95% | +66.35% | The five-year operational turnaround concludes with the corporate identity firmly repositioned into high-value specialty materials. Valuation multiples settle near normalized through-cycle levels as disciplined capital allocation delivers durable shareholder yields. |
The investment thesis centers on an asymmetric capital-cycle transition: shifting from aggressive, debt-financed capacity buildouts toward high-margin asset harvesting and state-subsidized operational triage. While headline returns have been depressed by trailing petrochemical losses, collapsing ethylene-naphtha spreads, and interest coverage near parity, capital intensity has decisively peaked. Management's rationalization of uncompetitive domestic crackers combined with commercialization at the Tennessee cathode complex structurally lifts recurring operating profit. Downside is insulated by a conservative price-to-book valuation and an immense controlling equity stake in a publicly listed battery subsidiary. Valuation sensitivity remains acutely linked to execution speed in paring subsidiary equity and retiring expensive floating-rate debt. The primary counterargument warns that structural Chinese petrochemical overcapacity, elevated crude feedstocks, and Western electric vehicle demand deceleration could trap parent cash flows, leaving minority shareholders vulnerable to holding company governance penalties.
Key insights
- Captive North American battery material localization ring-fences high-nickel conversion margins from Asian price competition under strict bilateral critical-mineral trade mandates.
- Programmatic subsidiary equity monetization provides a multi-trillion-won non-dilutive liquidity bridge, systematically retiring high-coupon parent borrowings and compressing holding company discounts.
- Transitioning petrochemical capacity toward specialized electronic chemicals and bio-polymers decouples consolidated returns from commoditized olefins, structurally lifting normalized operating margins.
This business is navigating a pivotal turnaround from an unprofitable commodity chemical maker into a high-value materials specialist. For years, massive factory construction and cheap foreign competition severely drained cash. Today, construction spending is falling while lucrative overseas supply deals for advanced battery materials begin commercial deliveries. Backed by valuable corporate assets and a massive stake in its battery subsidiary, the company offers a compelling margin of safety against further downside.
Key insights
- Localized North American factories secure profitable, long-term supply contracts that foreign competitors cannot easily match.
- Selling small portions of its battery subsidiary generates enormous cash to repay debt without dilution.
- Shuttering unprofitable legacy chemical plants stops chronic cash drain, permanently improving underlying company profitability.
Deep Dive
Prevailing market sentiment treats the business as an impaired value trap burdened by relentless Chinese petrochemical dumping, sluggish global electric vehicle demand, and negative free cash flow. Sell-side commentary fixates on an intractable holding company discount, assuming underlying subsidiary asset value will remain permanently locked while uncompetitive domestic crackers bleed operating cash.